Kazutaka Suzuki Selected Research

Kazutaka Suzuki Research Topics

4	Insulin Resistance 12/2005 - 01/2002
3	Heart Failure 12/2019 - 01/2002
2	Hyponatremia 10/2015 - 11/2005
2	Essential Hypertension 12/2005 - 07/2005
1	COVID-19 01/2022
1	Atypical Hemolytic Uremic Syndrome 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Acute Promyelocytic Leukemia 01/2022
1	Hemolysis 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2020
1	Chylothorax 10/2015
1	Mycoses (Diseases, Fungus) 12/2009
1	Hyperinsulinism (Hyperinsulinemia) 12/2005
1	Hyperglycemia 12/2005
1	Hypercalciuria 11/2005
1	Bartter Syndrome (Syndrome, Bartter) 11/2005
1	Polyuria 11/2005
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2002

3	Glucose (Dextrose)FDA LinkGeneric 12/2005 - 03/2004
2	Pioglitazone (Actos)FDA Link 12/2005 - 07/2005
1	Complement System Proteins (Complement)IBA 01/2022
1	eculizumab FDA Link 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	AntigensIBA 01/2021
1	EndocannabinoidsIBA 02/2020
1	OrganophosphatesIBA 02/2020
1	EnzymesIBA 02/2020
1	Tolvaptan FDA Link 10/2015
1	Pharmaceutical PreparationsIBA 10/2015
1	Vasopressins (Vasopressin)IBA 10/2015
1	Ribosomal RNAIBA 12/2009
1	Insulin (Novolin)FDA Link 12/2005
1	MagnesiumIBA 11/2005
1	AldosteroneIBA 11/2005
1	Sodium Chloride FDA LinkGeneric 11/2005
1	Matrix Metalloproteinases (MMPs)IBA 07/2005
1	AdiponectinIBA 07/2005
1	Angiotensin IIIBA 01/2002
1	PotassiumIBA 01/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2002
1	CationsIBA 01/2002
1	Nifedipine (Adalat)FDA LinkGeneric 01/2002

1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Induction Chemotherapy 01/2022
1	Therapeutics 12/2019
1	Artificial Heart (Artificial Hearts) 12/2019
1	Palliative Care (Palliative Therapy) 10/2015